Charles River Laboratories, Wilmington, MA

Charles River Laboratories

www.criver.com

At Charles River, we are passionate about our role in improving the quality of people`s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

Number of Employees: 1K-5K
Annual Revenue: > $1 Billion

www.criver.com
251 Ballardvale Street
Wilmington, MA USA 01887
Phone: 781.222.6000

Executives

Name	Title	Contact Details
Gerard Cardillo	Chief Procurement Officer	Profile
Flavia Pease	Chief Financial Officer	Profile
Caroline Desjardins Smith	Executive Director, Global HR Transformation	Profile
Ryan Maynes	Associate Director of HR Operations	Profile
Norman Wainwright	Senior Director, Research & Development	Profile

Similar Companies

Ossium Health

Ossium is building the world`s first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.

Regenxbio

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO`s NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO`s mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO`s NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.

HR Execs on the Move